Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus (Q24200376)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

meta-analysis

0 references

title

Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

0 references

0 references

Birgit Fullerton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Klaus Jeitler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Mirjam Seitz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Karl Horvath

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Andrea Berghold

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Andrea Siebenhofer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

14 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

CD009122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT S

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The Minnesota diabetes complications clinical trial the first three years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Severe Hypoglycemia During Maximized Insulin Treatment of Diabetes in a Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Conventional versus intensive diabetes therapy in children with type 1 diabetes: effects on memory and motor speed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Self-care autonomy and outcomes of intensive therapy or usual care in youth with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Self-management competence as a predictor of outcomes of intensive therapy or usual care in youth with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients: a 2 year controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Near normoglycemia for 1 year has no effect on platelet reactivity, factor VIII, and von Willebrand factor in insulin-dependent diabetes mellitus: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Sustained normoglycemia and remission phase in newly diagnosed type I diabetic subjects. Comparison between continuous subcutaneous insulin infusion and conventional therapy during a one year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Delayed progression of diabetic retinopathy by divided insulin administration: a further follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

A randomized controlled trial of Sweet Talk, a text-messaging system to support young people with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Sustained normoglycemia in newly diagnosed type I diabetic subjects. Short-term effects and one-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Plasma somatostatin and plasma glucagon in long-term IDDM without residual B-cell function. No effect of different long-term metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Are systematic reviews up-to-date at the time of publication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Implementation of intensified insulin therapy: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Diabetic somatic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Enhanced glucose control for preventing and treating diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of the quality and outcomes framework on diabetes care in the United Kingdom: retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Large trials vs meta-analysis of smaller trials: how do their results compare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Temporal patterns in overweight and obesity in Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The barrier of hypoglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Hypoglycemia, diabetes, and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Meta-analysis of small trials: proceed with caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of lipid reduction on the progression of renal disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Anxiety symptoms in adolescents with type 1 diabetes: association with blood glucose monitoring and glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

A re-evaluation of random-effects meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The changing natural history of nephropathy in type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Optimal blood glucose control during 18 years preserves peripheral nerve function in patients with 30 years' duration of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Epidemiology of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Influence of intensive versus conventional glucose control on microvascular and macrovascular complications in type 1 and 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Structural-functional relationships in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Depressive symptoms and glycemic control in adolescents with type 1 diabetes: mediational role of blood glucose monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Glycemic control in type 2 diabetes: time for an evidence-based about-face?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidøre Study Group on Childhood Diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Insulin treatment and cardiovascular disease; friend or foe? A point of view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effectiveness of disease-management programs for improving diabetes care: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Increasing incidence of Type 1 diabetes--role for genes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Meta-analysis of small randomized controlled trials in surgery may be unreliable

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration: the joslin 50-year medalist study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Recent advances in treatment of youth with Type 1 diabetes: better care through technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Vascular risk factors and diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Viral infections as potential triggers of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Diabetic autonomic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Glycemia and cardiovascular disease in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Properties of the urn randomization in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? The 'dead in bed' syndrome revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Intensified glucose lowering in type 2 diabetes: time for a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Severe hypoglycemia and risks of vascular events and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD009122.PUB2

Effect of intensive therapy on early macrovascular disease in young individuals with type 1 diabetes. A systematic review and meta-analysis.

21 January 2018

1 reference

12 December 2020

Intensive insulin therapy compared with conventional insulin therapy does not reduce depressive symptoms in parents of children with type 1 diabetes

1 reference

12 December 2020

How well are we doing? - Metabolic control in patients with diabetes

1 reference

12 December 2020

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy, by The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N. Engl. J.

1 reference

12 December 2020

Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy

1 reference

12 December 2020

Report of the expert committee on the diagnosis and classification of diabetes mellitus

1 reference

12 December 2020

Absence of adverse effects of severe hypoglycemia on cognitive function in school-aged children with diabetes over 18 months

1 reference

12 December 2020

Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria

1 reference

12 December 2020

Stressors and self-care challenges faced by adolescents living with type 1 diabetes

1 reference

12 December 2020

Intensive management of type 1 diabetes in young children

1 reference

12 December 2020

Tight control can protect your heart

1 reference

12 December 2020

Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus

1 reference

12 December 2020

Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic control

1 reference

12 December 2020

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus

1 reference

12 December 2020

Sudden death in type 1 diabetes: the mystery of the 'dead in bed' syndrome

1 reference

12 December 2020

Utilization of an abbreviated diabetes impact management scale to assess change in subjective disability during a trial of pulsatile insulin delivery demonstrates benefit

1 reference

12 December 2020

Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

1 reference

12 December 2020

Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps

1 reference

12 December 2020

Multiple insulin injection therapy as intensive insulin therapy

1 reference

12 December 2020

Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement

1 reference

12 December 2020

Diabetes Control and Complications Trial (DCCT). Update. DCCT Research Group

1 reference

12 December 2020

Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial

1 reference

12 December 2020

The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group

1 reference

12 December 2020

Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group

1 reference

12 December 2020

Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

1 reference

12 December 2020

Diabetic retinopathy after two years of intensified insulin treatment. Follow-up of the Kroc Collaborative Study. The Kroc Collaborative Study Group

1 reference

12 December 2020

Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control

1 reference

12 December 2020

[Metabolic control in labile type I diabetes with conventional insulin therapy, basal bolus insulin therapy using pens and continuous subcutaneous insulin infusion with the pump]

1 reference

12 December 2020

[Effects of intensified insulin therapy on fat metabolism in type 1 diabetes mellitus]

1 reference

12 December 2020

Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment

1 reference

12 December 2020

Long-term correction of hyperglycemia and progression of retinopathy in insulin dependent diabetes. A five-year randomized prospective study

1 reference

12 December 2020

Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study

1 reference

12 December 2020

Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study

1 reference

12 December 2020

Renal transplantation at the University of Minnesota during the 1980s

1 reference

12 December 2020

Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study

1 reference

12 December 2020

[Comparison of metabolic control between the continuous subcutaneous insulin infusion pump and augmented conventional treatment. Effects after 12 months]

1 reference

12 December 2020

A comparative study of intensive conventional insulin treatment and a multiple insulin-injection regimen with NovoPen

1 reference

12 December 2020

Near-normoglycemia and late diabetic complications. The Oslo Study

1 reference

12 December 2020

[Comparison of the effectiveness of conventional and intensive insulin therapy in the treatment of diabetes mellitus type 1 in pregnant women or those planning pregnancy]

1 reference

12 December 2020

Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus

1 reference

12 December 2020

A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy

1 reference

12 December 2020

Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy

1 reference

12 December 2020

Effect of long-term near-normoglycemia on the progression of diabetic nephropathy

1 reference

12 December 2020

Effects of intensified insulin treatment on various lesions of diabetic retinopathy

1 reference

12 December 2020

Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study

1 reference

12 December 2020

Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics

1 reference

12 December 2020

Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study

1 reference

12 December 2020

The Minnesota Diabetes Complications Clinical Trial cognitive functions under long-term maximized and standard metabolic controls

1 reference

12 December 2020

[Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin]

1 reference

12 December 2020

Implanted constant basal rate insulin infusion devices for Type 1 (insulin-dependent) diabetic patients

1 reference

12 December 2020

Implementation of treatment protocols in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom

1 reference

12 December 2020

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial

1 reference

12 December 2020

Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group

1 reference

12 December 2020

Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial

1 reference

12 December 2020

The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial

1 reference

12 December 2020

The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study

1 reference

12 December 2020

Reproducibility of a comprehensive diet history in the Diabetes Control and Complications Trial. The DCCT Research Group

1 reference

12 December 2020

Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research

1 reference

12 December 2020

Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients

1 reference

12 December 2020

Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes

1 reference

12 December 2020

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

12 December 2020

Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. A multicenter controlled study

1 reference

12 December 2020

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Pregnancy outcomes in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Lens changes during rapid tightening of metabolic control in diabetes

1 reference

12 December 2020

Frequency of hypoglycemic episodes during intensive therapy with human insulin

1 reference

12 December 2020

Adverse events and their association with treatment regimens in the diabetes control and complications trial

1 reference

12 December 2020

Resource utilization and costs of care in the diabetes control and complications trial

1 reference

12 December 2020

Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial

1 reference

12 December 2020

The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial

1 reference

12 December 2020

Familial factors determine the development of diabetic nephropathy in patients with IDDM.

1 reference

12 December 2020

Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients

1 reference

12 December 2020

Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes

1 reference

12 December 2020

Unravelling a complex trait: the genetics of insulin-dependent diabetes mellitus

1 reference

12 December 2020

Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control

1 reference

12 December 2020

Improved metabolic control preserved beta-cell function two years after diagnosis of insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1 reference

12 December 2020

Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

1 reference

12 December 2020

The effects of treatment on the direct costs of diabetes

1 reference

12 December 2020

[Costs of intensive insulin therapy in type 1 diabetes mellitus. Experiences from the DCCT study]

1 reference

12 December 2020

10.1002/14651858.CD009122.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3288331

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

release_fkj4op363zejnhtk7ssfnzfjcu

7 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fkj4op363zejnhtk7ssfnzfjcu

24 November 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

3288331

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24526393%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference